Put Options

8 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

May 14, 2024

BUY
$902.69 - $993.35 $3.7 Million - $4.07 Million
4,100 Added 141.38%
7,000 $6.74 Million
Q4 2023

Feb 14, 2024

BUY
$775.18 - $881.7 $2.02 Million - $2.29 Million
2,600 Added 866.67%
2,900 $2.55 Million
Q3 2023

Nov 14, 2023

SELL
$692.45 - $844.37 $553,960 - $675,496
-800 Reduced 72.73%
300 $246,000
Q2 2023

Aug 14, 2023

BUY
$700.03 - $830.35 $770,033 - $913,385
1,100 New
1,100 $790,000
Q4 2022

Feb 14, 2023

SELL
$705.89 - $766.39 $211,767 - $229,917
-300 Reduced 5.56%
5,100 $3.68 Million
Q3 2022

Nov 14, 2022

BUY
$573.97 - $724.32 $3.1 Million - $3.91 Million
5,400 New
5,400 $3.72 Million
Q1 2022

May 13, 2022

BUY
$595.12 - $698.43 $595,120 - $698,430
1,000 Added 18.52%
6,400 $4.47 Million
Q4 2021

May 03, 2022

BUY
$543.48 - $670.97 $2.93 Million - $3.62 Million
5,400 New
5,400 $3.41 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.6B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.